RxDoctor Payments Data

Benjamin Sanders, DO

Psychiatry · Indianapolis, INNPI 1720548621

Payments from drug & device makers

$729in general payments, 2019–2025

Across 41 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$164
  • Vanda Pharmaceuticals Inc.$138
  • Johnson & Johnson$98
  • AbbVie$84
  • Alkermes, Inc.$51
  • Otsuka America Pharmaceutical, Inc.$46
  • plus $148 from 6 others

What the payments were for

  • Food & beverage$71498%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$729 in reported general payments places this provider in the 60th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$3,616
Medicare patients
24
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$109,195
VraylarCariprazine Hcl23$36,571
TrintellixVortioxetine Hydrobromide20$12,643
Aripiprazole65$11,310
FetzimaLevomilnacipran Hcl11$6,290
Ziprasidone Hcl47$4,510
Bupropion XlBupropion Hcl180$2,843
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine32$2,820
Vilazodone Hcl38$2,810
Trazodone Hcl151$2,320
Duloxetine Hcl99$1,799
Buspirone Hcl114$1,554
Divalproex Sodium ErDivalproex Sodium41$1,419
Fluoxetine Hcl94$1,400
Paliperidone ErPaliperidone14$1,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$42$109,19514 claims
AbbVieVraylar, Fetzima$84$42,86234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →